Indian Kit Exporters: Complete Supplier Ranking with Market Share — 1048 Manufacturers (2026) — TransData Nexus

Q: Who is the largest kit supplier from India?

LUPIN LIMITED is the largest kit exporter from India with a 62.1% market share and export value of $270.8M.

Q: How many kit suppliers are there in India?

There are 1048 active kit exporters in India, collectively shipping $436.3M worth of kit across 15,000 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top kit suppliers from India?

The top 5 kit suppliers from India — LUPIN LIMITED, PAR FORMULATIONS PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED, MACLEODS PHARMACEUTICALS LTD, CIPLA LIMITED — together control 76.2% of total kit export value from India.

Suresh Sormare

Kit

India Pharmaceutical Trade Intelligence

$436.3M1,048 Suppliers191 CountriesHS 30049099

ExportsIndia → NIGERIA60.5%India → UNITED STATES7.4%

#1 Supplier: LUPIN LIMITED #1 Buyer: NATIONAL TUBERCULOSIS

Kit Suppliers from India (2026) — 1048 Exporters, $436.3M Market | TransData Nexus | TransData Nexus

Who Exports Kit from India — 1048 Suppliers Behind a $436.3M Market

India's kit export market is supplied by 1048 active exporters who collectively shipped $436.3M across 15,000 shipments. LUPIN LIMITED leads with a 62.1% market share, followed by PAR FORMULATIONS PRIVATE LIMITED and RELIANCE LIFE SCIENCES PRIVATE LIMITED. The top 5 suppliers together control 76.2% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published March 2026·

India's Top Kit Suppliers & Exporters — 1048 manufacturers, $436.3M export market, top destinations and formulations — Kit supplier data — 1048 exporters · $436.3M market · 15,000 shipmentsTransData Nexus · Indian Customs Data

Top Kit Exporters from India — Ranked by Export Value

LUPIN LIMITED is the leading kit exporter from India, holding a 62.1% share of the $436.3M market across 15,000 shipments from 1048 exporters. The top 5 suppliers — LUPIN LIMITED, PAR FORMULATIONS PRIVATE LIMITED, RELIANCE LIFE SCIENCES PRIVATE LIMITED, MACLEODS PHARMACEUTICALS LTD, CIPLA LIMITED — collectively control 76.2% of total export value, indicating a highly concentrated market. Individual shares are: LUPIN LIMITED (62.1%), PAR FORMULATIONS PRIVATE LIMITED (6.1%), RELIANCE LIFE SCIENCES PRIVATE LIMITED (3.2%), MACLEODS PHARMACEUTICALS LTD (2.8%), CIPLA LIMITED (2.0%).

Top Kit Exporters from India

Ranked by export value · 1048 active suppliers · Indian Customs (DGFT) data

Mar 2026

Top Kit Exporters from India — Ranked by Export Value. 1048 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share
1	LUPIN LIMITED

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Kit exporters

Certification and compliance status for top Kit suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
LUPIN LIMITED	Approved	Yes	Yes	Multiple	FDA inspection at Somerset facility concluded with zero observations in February
CIPLA LIMITED	Approved	Yes	Yes	Multiple	FDA approved Cipla's generic Acyclovir Cream, 5% in May 2025.
MACLEODS PHARMACEUTICALS LTD	Approved	Yes	Yes	Multiple	Listed as an approved manufacturer by LMHRA through WHO-GMP desk audit. (lmhra.g
MICRO LABS LIMITED	Approved	Yes	Yes	Multiple	Operates 14 GMP-compliant manufacturing plants catering to regulated markets.
SUN PHARMACEUTICAL INDUSTRIES LIMITED	Approved	Yes	Yes	Multiple	Recognized for compliance with international regulatory standards.
SANDOZ PRIVATE LIMITED	Approved	Yes	Yes	Multiple	Maintains compliance with global regulatory requirements.
AJANTA PHARMA LIMITED	Approved	Yes	Yes	Multiple	Holds certifications from major regulatory bodies.
ALKEM LABORATORIES LIMITED	Approved	Yes	Yes	Multiple	Listed as an approved applicant under the PLI scheme for pharmaceuticals.

TransData Nexus reviewed the regulatory standing of 8 leading Kit exporters from India. 8 hold US FDA facility approvals, 8 maintain WHO-GMP certification, and 8 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Kit sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," contributes approximately 40% of the country's bulk drug production. This prominence is bolstered by the establishment of Hyderabad Pharma City, a vast integrated pharmaceutical industrial park spanning over 19,000 acres in Mucherla, designed to foster a self-sustained ecosystem for pharmaceutical manufacturing and research. The city's pharmaceutical landscape is further enriched by the presence of major companies such as Dr. Reddy's Laboratories and Aurobindo Pharma, which have significantly contributed to its status as a global pharmaceutical hub.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat has emerged as a significant hub for pharmaceutical formulations. Vadodara, in particular, hosts numerous pharmaceutical companies, including Alembic Pharmaceuticals, which specializes in the production of active pharmaceutical ingredients (APIs) and formulations. The region's strategic location and well-established infrastructure make it a pivotal center for the manufacturing and export of pharmaceutical formulations.

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Kit exporters from India

April 2, 2025

M&A

LUPIN LIMITED — Lupin acquires UK-based Renascience Pharma for GBP 12.3 million

Lupin Healthcare (UK) Limited, a wholly owned subsidiary of Lupin Limited, acquired Renascience Pharma Limited, a UK-based pharmaceutical company, for GBP 12.3 million. Renascience supplies niche branded bio-generic products in the UK, including injectables for infectious diseases and ear drops for pain management. IMPACT: This acquisition is expected to enhance Lupin's product portfolio, potentially increasing kit exports to the UK.

Impact: This acquisition is expected to enhance Lupin's product portfolio, potentially increasing kit exports to the UK.

October 4, 2024

M&A

LUPIN LIMITED — Lupin acquires nine brands from Medical Nutritional Institute in South Africa

Lupin's South African subsidiary, Pharma Dynamics, acquired nine brands from the Medical Nutritional Institute SA, including products addressing metabolic syndrome and cognitive function. IMPACT: This acquisition may strengthen Lupin's presence in South Africa, potentially boosting kit exports to the region.

Impact: This acquisition may strengthen Lupin's presence in South Africa, potentially boosting kit exports to the region.

Common Questions — Kit Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which kit supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, LUPIN LIMITED leads with 108 recorded shipments worth $270.8M. PAR FORMULATIONS PRIVATE LIMITED (49 shipments) and RELIANCE LIFE SCIENCES PRIVATE LIMITED (54 shipments) are also established high-volume exporters.

Q How many kit manufacturers are there in India?

India has 1048 active kit exporters with a combined export market of $436.3M across 15,000 shipments to 191 countries. The top 5 suppliers hold 76.2% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Kit

Kit